Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
13/02/2012 | 17:55 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
13/02/2012 | 14:22 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
13/02/2012 | 12:03 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
09/02/2012 | 19:13 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
07/02/2012 | 15:00 | Marketwired | A Forward Look, the Year Ahead - Featured Research on Inhibitex, Inc. and Idenix Pharmaceuticals, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
06/02/2012 | 14:18 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
03/02/2012 | 21:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
26/01/2012 | 18:32 | Dow Jones News | UPDATE: Bristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss Views | NASDAQ:INHX | Inhibitex, Inc. (MM) |
26/01/2012 | 15:11 | Dow Jones News | Bristol-Myers 4Q Net Up 76% On Lower Taxes But Results Miss Views | NASDAQ:INHX | Inhibitex, Inc. (MM) |
26/01/2012 | 14:56 | Zacks | Bristol-Myers Misses on All Fronts - Analyst Blog | NASDAQ:INHX | Inhibitex, Inc. (MM) |
23/01/2012 | 10:00 | Zacks | Earnings Preview: Bristol-Myers - Analyst Blog | NASDAQ:INHX | Inhibitex, Inc. (MM) |
20/01/2012 | 09:30 | Zacks | The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals & Merck - Press R.. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
19/01/2012 | 14:15 | Zacks | Gilead Clinches Pharmasset Buy - Analyst Blog | NASDAQ:INHX | Inhibitex, Inc. (MM) |
17/01/2012 | 22:37 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
17/01/2012 | 12:15 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
13/01/2012 | 22:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
13/01/2012 | 22:21 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
13/01/2012 | 20:07 | Marketwired | The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Inhibitex, I... | NASDAQ:INHX | Inhibitex, Inc. (MM) |
11/01/2012 | 17:50 | PR Newswire (US) | Potentially Unfair Tender Offer for Inhibitex Triggers Shareholder-Claim Investigation by Securities Class Action Lawyers at ... | NASDAQ:INHX | Inhibitex, Inc. (MM) |
11/01/2012 | 02:28 | Dow Jones News | Merck Will Consider Deals To Expand Hepatitis C Drug Lineup | NASDAQ:INHX | Inhibitex, Inc. (MM) |
11/01/2012 | 01:06 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibi... | NASDAQ:INHX | Inhibitex, Inc. (MM) |
11/01/2012 | 01:00 | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 22:17 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 21:57 | Business Wire | Law Firm Brower Piven Announces Investigation of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 16:37 | Business Wire | Ryan & Maniskas, LLP Announces Investigation of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 12:04 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 09:30 | Zacks | The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset - Press Releases | NASDAQ:INHX | Inhibitex, Inc. (MM) |
10/01/2012 | 01:03 | Business Wire | Law Offices of Howard G. Smith Announces Investigation of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
09/01/2012 | 22:02 | Business Wire | Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |
09/01/2012 | 19:10 | Business Wire | Harwood Feffer LLP Announces Investigation of Inhibitex, Inc. | NASDAQ:INHX | Inhibitex, Inc. (MM) |